Comparing Qulipta vs Relpax

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Qulipta (atogepant)	Relpax (eletriptan)	Enter another drug to compare

Qulipta (atogepant)

Relpax (eletriptan)

Prescription only

Prescribed for Chronic Migraine, Migraine Prevention. Qulipta may also be used for purposes not listed in this medication guide.

Prescription only

Prescribed for Migraine. Relpax may also be used for purposes not listed in this medication guide.

More about Qulipta (atogepant)

More about Relpax (eletriptan)

Ratings & Reviews

Qulipta has an average rating of 8.1 out of 10 from a total of 181 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 7% reported a negative effect.

Relpax has an average rating of 8.6 out of 10 from a total of 153 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 10% reported a negative effect.

View all 181 reviews

View all 153 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

Constipation (14.4%)
Nausea (7.7%)
Fatigue (6.1%)
Loss of appetite (4.4%)
Tiredness (3.9%)
Dizziness (2.8%)
Weight loss (2.8%)

View all Qulipta side effects

Nausea (11.1%)
Tiredness (7.8%)
Drowsiness (6.5%)
Pain (5.9%)
Vomiting (4.6%)
Lightheadedness (3.3%)
Headaches (2.6%)

View all Relpax side effects

Drug Class

CGRP inhibitors

Antimigraine agents

Generic Availability

No lower cost generic approved

Lower cost generic approved

Pricing and Coupons * Prices are without insurance

Quantity	30 tablet
Strength	10 mg
Per unit^*	$41.16
Cost^*	$1,234.67

View all Qulipta prices

Quantity	6 tablet
Strength	40 mg
Per unit^*	$87.89
Cost^*	$527.33

View all Relpax prices

Get free Discount Card

Dosage Forms

Oral tablet

Oral tablet

Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

11 hours

6 hours

CSA Schedule ¹ View glossary of CSA terms

Not a controlled drug

Is not subject to the Controlled Substances Act.

Not a controlled drug

Is not subject to the Controlled Substances Act.

Pregnancy Category

Summary unavailable.

See the full pregnancy warnings document.

Category C Risk cannot be ruled out

See the full pregnancy warnings document.

Drug Interactions

A total of 194 drugs are known to interact with Qulipta:

80 major drug interactions (224 brand and generic names)
14 moderate drug interactions (29 brand and generic names)
100 minor drug interactions (304 brand and generic names)

A total of 247 drugs are known to interact with Relpax:

98 major drug interactions (368 brand and generic names)
144 moderate drug interactions (492 brand and generic names)
5 minor drug interactions (14 brand and generic names)

Alcohol/Food/Lifestyle Interactions

No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Disease Interactions

First Approval Date

September 28, 2021

December 26, 2002

WADA Class View classifications

N/A

More Information

Patient Resources

Qulipta uses

Relpax uses

Professional Resources

Prescribing information

Prescribing information

¹ The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Comparing Qulipta vs Relpax

See also:

Botox

Nurtec ODT

Aimovig

Emgality

Inderal

Ajovy

Vyepti

Botox Cosmetic

Fremanezumab

OnabotulinumtoxinA

Further information

Comparing Qulipta vs Relpax

See also:

Further information

Compare Drugs